AcrAB−TolC, a major efflux pump in Gram negative bacteria: toward understanding its operation mechanism

키워드

참고문헌 (97)

1. Antimicrobial Resistance C, "Global burden of bacterial antimicrobial resistance in 2019 : a systematic analysis", Lancet, 399, pp.629~655 (2022)
2. Tacconelli E, "Discovery, research, and development of new antibiotics : the WHO priority list of antibiotic-resistant bacteria and tuberculosis", Lancet Infect Dis, 18, pp.318~327 (2018)
3. Blair JM, "Molecular mechanisms of antibiotic resistance", Nat Rev Microbiol, 13, pp.42~51 (2015)
4. Arzanlou M, "Intrinsic, adaptive and acquired antimicrobial resistance in Gramnegative bacteria", Essays Biochem, 61, pp.49~59 (2017)
5. Langevin AM, "Mapping the role of AcrAB-TolC efflux pumps in the evolution of antibiotic resistance reveals Near-MIC treatments facilitate resistance acquisition", mSphere, 5, pp.e01056~20 (2020)
6. Hernando-Amado S, "Multidrug efflux pumps as main players in intrinsic and acquired resistance to antimicrobials", Drug Resist Updat, 28, pp.13~27 (2016)
7. Li XZ, "The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria", Clin Microbiol Rev, 28, pp.337~418 (2015)
8. Hassan KA, "Homologs of the Acinetobacter baumannii AceI transporter represent a new family of bacterial multidrug efflux systems", mBio, 6, pp.e01982-14~ (2015)
9. Alnaseri H, "Inducible expression of a resistance-nodulation-division-type efflux pump in Staphylococcus aureus provides resistance to linoleic and arachidonic acids", J Bacteriol, 197, pp.1893~1905 (2015)
10. Schindler BD, "Analyses of multidrug efflux pump-like proteins encoded on the Staphylococcus aureus chromosome", Antimicrob Agents Chemother, 59, pp.747~748 (2015)
11. Du D, "Multidrug efflux pumps : structure, function and regulation", Nat Rev Microbiol, 16, pp.523~539 (2018)
12. Nikaido H, "RND transporters in the living world", Res Microbiol, 169, pp.363~371 (2018)
13. Kobylka J, "AcrB : a mean, keen, drug efflux machine", Ann N Y Acad Sci, 1459, pp.38~68 (2020)
14. Alav I, "Structure, assembly, and function of tripartite efflux and type 1 secretion systems in gram-negative bacteria", Chem Rev, 121, pp.5479~5596 (2021)
15. Puzari M, "RND efflux pump mediated antibiotic resistance in Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa : a major issue worldwide", World J Microbiol Biotechnol, 33, pp.24~ (2017)
16. Lorusso AB, "Role of efflux pumps on antimicrobial resistance in Pseudomonas aeruginosa", Int J Mol Sci, 23, pp.15779~ (2022)
17. Wieczorek P, "Multidrug resistant Acinetobacter baumannii--the role of AdeABC(RND family)efflux pump in resistance to antibiotics", Folia Histochem Cytobiol, 46, pp.257~267 (2008)
18. Su CC, "Structures and transport dynamics of a Campylobacter jejuni multidrug efflux pump", Nat Commun, 8, pp.171~ (2017)
19. Bolla JR, "Crystal structure of the Neisseria gonorrhoeae MtrD inner membrane multidrug efflux pump", PLoS One, 9, pp.e97903~ (2014)
20. Nikaido H, "AcrAB and related multidrug efflux pumps of Escherichia coli", J Mol Microbiol Biotechnol, 3, pp.215~218 (2001)
21. Yamasaki S, "Multidrug efflux pumps contribute to Escherichia coli biofilm maintenance", Int J Antimicrob Agents, 45, pp.439~441 (2015)
22. Bay DC, "Secondary multidrug efflux pump mutants alter Escherichia coli biofilm growth in the presence of cationic antimicrobial compounds", Res Microbiol, 168, pp.208~221 (2017)
23. Perez A, "Involvement of the AcrAB-TolC efflux pump in the resistance, fitness, and virulence of Enterobacter cloacae", Antimicrob Agents Chemother, 56, pp.2084~2090 (2012)
24. Webber MA, "The global consequence of disruption of the AcrAB-TolC efflux pump in Salmonella enterica includes reduced expression of SPI-1 and other attributes required to infect the host", J Bacteriol, 191, pp.4276~4285 (2009)
25. Langevin AM, "Stress introduction rate alters the benefit of AcrAB-TolC efflux pumps", J Bacteriol, 200, pp.e00525~17 (2018)
26. Compagne N, "Update on the discovery of efflux pump inhibitors against critical priority gramnegative bacteria", Antibiotics(Basel), 12, pp.180~ (2023)
27. Alenazy R, "Drug efflux pump inhibitors : a promising approach to counter multidrug resistance in gramnegative pathogens by targeting AcrB protein from AcrABTolC multidrug efflux pump from Escherichia coli", Biology(Basel), 11, pp.1328~ (2022)
28. Du D, "Structure of the AcrAB-TolC multidrug efflux pump", Nature, 509, pp.512~515 (2014)
29. Daury L, "Tripartite assembly of RND multidrug efflux pumps", Nat Commun, 7, pp.10731~ (2016)
30. Chen M, "In situ structure of the AcrAB-TolC efflux pump at subnanometer resolution", Structure, 30, pp.107~113 (2022)
31. Wang Z, "An allosteric transport mechanism for the AcrAB-TolC multidrug efflux pump", Elife, 6, pp.24905~ (2017)
32. Su CC, "Conformation of the AcrB multidrug efflux pump in mutants of the putative proton relay pathway", J Bacteriol, 188, pp.7290~7296 (2006)
33. Zwama M, "Multiple entry pathways within the efflux transporter AcrB contribute to multidrug recognition", Nat Commun, 9, pp.124~ (2018)
34. Qiu W, "Structure and activity of lipid bilayer within a membrane-protein transporter", Proc Natl Acad Sci U S A, 115, pp.12985~12990 (2018)
35. Muller RT, "Switch loop flexibility affects substrate transport of the AcrB efflux pump", J Mol Biol, 429, pp.3863~3874 (2017)
36. Eicher T, "Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop", Proc Natl Acad Sci U S A, 109, pp.5687~5692 (2012)
37. Rajapaksha P, "Probing the dynamics of AcrB through disulfide bond formation", ACS Omega, 5, pp.21844~21852 (2020)
38. Koronakis V, "Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export", Nature, 405, pp.914~919 (2000)
39. Hobbs EC, "Conserved small protein associates with the multidrug efflux pump AcrB and differentially affects antibiotic resistance", Proc Natl Acad Sci U S A, 109, pp.16696~16701 (2012)
40. Jeong H, "Pseudoatomic Structure of the tripartite multidrug efflux pump AcrABTolC reveals the intermeshing cogwheel-like interaction between AcrA and TolC", Structure, 24, pp.272~276 (2016)
41. Du D, "Interactions of a bacterial RND transporter with a transmembrane small protein in a lipid environment", Structure, 28, pp.625~634e626 (2020)
42. Shi X, "In situ structure and assembly of the multidrug efflux pump AcrAB-TolC", Nat Commun, 10, pp.2635~ (2019)
43. Koronakis V, "Channeltunnels", Curr Opin Struct Biol, 11, pp.403~407 (2001)
44. Koronakis V, "TolC--the bacterial exit duct for proteins and drugs", FEBS Lett, 555, pp.66~71 (2003)
45. Zgurskaya HI, "Mechanism and function of the outer membrane channel TolC in multidrug resistance and physiology of Enterobacteria", Front Microbiol, 2, pp.189~ (2011)
46. Mikolosko J, "Conformational flexibility in the multidrug efflux system protein AcrA", Structure, 14, pp.577~587 (2006)
47. Neuberger A, "Structure and mechanism of bacterial tripartite efflux pumps", Res Microbiol, 169, pp.401~413 (2018)
48. Seeger MA, "Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism", Science, 313, pp.1295~1298 (2006)
49. Murakami S, "Crystal structures of a multidrug transporter reveal a functionally rotating mechanism", Nature, 443, pp.173~179 (2006)
50. Seeger MA, "The AcrB efflux pump : conformational cycling and peristalsis lead to multidrug resistance", Curr Drug Targets, 9, pp.729~749 (2008)
51. Murakami S, "Crystal structure of bacterial multidrug efflux transporter AcrB", Nature, 419, pp.587~593 (2002)
52. Fischer N, "Porter domain opening and closing motions in the multi-drug efflux transporter AcrB", Biochim Biophys Acta, 1828, pp.632~641 (2013)
53. Eicher T, "Coupling of remote alternating-access transport mechanisms for protons and substrates in the multidrug efflux pump AcrB", Elife, 3, pp.e03145~ (2014)
54. Yue Z, "Constant pH molecular dynamics reveals how proton release drives the conformational transition of a transmembrane efflux pump", J Chem Theory Comput, 13, pp.6405~6414 (2017)
55. Webber A, "A model for allosteric communication in drug transport by the AcrAB-TolC tripartite efflux pump", Antibiotics(Basel), 11, pp.52~ (2022)
56. Sennhauser G, "Drug export pathway of multidrug exporter AcrB revealed by DARPin inhibitors", PLoS Biol, 5, pp.e7~ (2007)
57. Nakashima R, "Structures of the multidrug exporter AcrB reveal a proximal multisite drug-binding pocket", Nature, 480, pp.565~569 (2011)
58. Husain F, "Substrate path in the AcrB multidrug efflux pump of Escherichia coli", Mol Microbiol, 78, pp.320~330 (2010)
59. Husain F, "Vestibules are part of the substrate path in the multidrug efflux transporter AcrB of Escherichia coli", J Bacteriol, 193, pp.5847~5849 (2011)
60. Tam HK, "Binding and transport of carboxylated drugs by the multidrug transporter AcrB", J Mol Biol, 432, pp.861~877 (2020)
61. Oswald C, "Transport of lipophilic carboxylates is mediated by transmembrane helix 2in multidrug transporter AcrB", Nat Commun, 7, pp.13819~ (2016)
62. Tam HK, "Allosteric drug transport mechanism of multidrug transporter AcrB", Nat Commun, 12, pp.3889~ (2021)
63. Kobayashi N, "Beta-Lactam selectivity of multidrug transporters AcrB and AcrD resides in the proximal binding pocket", J Biol Chem, 289, pp.10680~10690 (2014)
64. Schuster S, "Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitors", Antimicrob Agents Chemother, 58, pp.6870~6878 (2014)
65. Sjuts H, "Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives", Proc Natl Acad Sci U S A, 113, pp.3509~3514 (2016)
66. Nikaido H, "Multidrug efflux pump AcrAB of Salmonella typhimurium excretes only those beta-lactam antibiotics containing lipophilic side chains", J Bacteriol, 180, pp.4686~4692 (1998)
67. Ornik-Cha A, "Structural and functional analysis of the promiscuous AcrB and AdeB efflux pumps suggests different drug binding mechanisms", Nat Commun, 12, pp.6919~ (2021)
68. Vargiu AV, "Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations", Proc Natl Acad Sci U S A, 109, pp.20637~20642 (2012)
69. Kinana AD, "Some ligands enhance the efflux of other ligands by the Escherichia coli multidrug pump AcrB", Biochemistry, 52, pp.8342~8351 (2013)
70. Davis K, "Leveraging laboratory and clinical studies to design effective antibiotic combination therapy", Curr Opin Microbiol, 64, pp.68~75 (2021)
71. Blair JM, "Expression of homologous RND efflux pump genes is dependent upon AcrB expression : implications for efflux and virulence inhibitor design", J Antimicrob Chemother, 70, pp.424~431 (2015)
72. Piddock LJ, "Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria", Clin Microbiol Rev, 19, pp.382~402 (2006)
73. Blair JM, "AcrB drugbinding pocket substitution confers clinically relevant resistance and altered substrate specificity", Proc Natl Acad Sci U S A, 112, pp.3511~3516 (2015)
74. Yang L, "Emergence of two AcrB substitutions conferring multidrug resistance to Salmonella spp", Antimicrob Agents Chemother, 65, pp.e01589-20~ (2023)
75. Opperman TJ, "Recent advances toward a molecular mechanism of efflux pump inhibition", Front Microbiol, 6, pp.421~ (2015)
76. Renau TE, "Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin", J Med Chem, 42, pp.4928~4931 (1999)
77. Nakashima R, "Structural basis for the inhibition of bacterial multidrug exporters", Nature, 500, pp.102~106 (2013)
78. Bohnert JA, "Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps", Antimicrob Agents Chemother, 49, pp.849~852 (2005)
79. chromene derivatives that target AcrB and reverse bacterial multidrug resistance, "Eur J Med Chem", 2021, 113049~
80. Opperman TJ, "Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli", Antimicrob Agents Chemother, 58, pp.722~733 (2014)
81. Ple C, "Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps", Nat Commun, 13, pp.115~ (2022)
82. Jesin JA, "Peptide-based approach to inhibition of the multidrug resistance efflux pump AcrB", Biochemistry, 59, pp.3973~3981 (2020)
83. Abdali N, "Reviving antibiotics : efflux pump inhibitors that interact with AcrA, a membrane fusion protein of the AcrAB-TolC multidrug efflux pump", ACS Infect Dis, 3, pp.89~98 (2017)
84. Darzynkiewicz ZM, "Identification of binding sites for efflux pump inhibitors of the AcrAB-TolC Component AcrA", Biophys J, 116, pp.648~658 (2019)
85. Grimsey EM, "Chlorpromazine and amitriptyline are substrates and inhibitors of the AcrB multidrug efflux pump", mBio, 11, pp.e00465-20~ (2020)
86. Sobhy MK, "3D-QSAR pharmacophore modelling, virtual screening and docking studies for lead discovery of a novel scaffold for VEGFR 2 inhibitors : design, synthesis and biological evaluation", Bioorg Chem, 89, pp.102988~ (2019)
87. Phan TV, "Discovery of AcrAB−TolC pump inhibitors: virtual screening and molecular dynamics simulation approach", J Biomol Struct Dyn, pp.1~18 (2023)
88. Abdel-Halim H, "The search of potential inhibitors of the AcrAB-TolC system of multidrug-resistant Escherichia coli : an in silico approach", Appl Microbiol Biotechnol, 103, pp.6309~6318 (2019)
89. Lomovskaya O, "Practical applications and feasibility of efflux pump inhibitors in the clinica vision for applied use", Biochem Pharmacol, 71, pp.910~918 (2006)
90. Bolla JM, "Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria", FEBS Lett, 585, pp.1682~1690 (2011)
91. Crass RL, "Pharmacokinetics and Pharmacodynamics of beta-Lactamase Inhibitors", Pharmacotherapy, 39, pp.182~195 (2019)
92. Reading E, "Perturbed structural dynamics underlie inhibition and altered efflux of the multidrug resistance pump AcrB", Nat Commun, 11, pp.5565~ (2020)
93. Pettersen EF, "UCSF ChimeraX : structure visualization for researchers, educators, and developers", Protein Sci, 30, pp.70~82 (2021)
94. Goddard TD, "UCSF ChimeraX : meeting modern challenges in visualization and analysis", Protein Sci, 27, pp.14~25 (2018)
95. Nikaido H, "Broad-specificity efflux pumps and their role in multidrug resistance of Gramnegative bacteria", FEMS Microbiol Rev, 36, pp.340~363 (2012)
96. Wang-Kan X, "Lack of AcrB efflux function confers loss of virulence on Salmonella enterica Serovar Typhimurium", mBio, 8, pp.e00968~17 (2017)
97. Atzori A, "Identification and characterization of carbapenem binding sites within the RND-transporter AcrB", Biochim Biophys Acta Biomembr, 1861, pp.62~74 (2019)

관련 논문AI추천